Japanese CRO Ties With U.K. Firm To Test Japan Makers' Drugs In EU
This article was originally published in PharmAsia News
Executive SummaryAcronet, a Japanese contract research organization, says it is collaborating with a similar company in the United Kingdom to offer more early phase clinical trials for Japanese companies operating in Europe
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.